The data available in the COSMIC dataset portal also indicate that Smurf2 is overexpressed in ~49% of ovarian cancer, about 18% of breast cancer, and in ~17% of soft tissue neoplasms. This evidence concerns the gene SMURF2 and breast carcinoma.